Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Pharma giant seeks to join lawsuit against FDA over weight loss drugs 

by
January 3, 2025
in Health Care
0
Pharma giant seeks to join lawsuit against FDA over weight loss drugs 

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some pharmacies have practiced in mass-marketing copies of its highly popular GLP-1 medications.

The lawsuit in question concerns the FDA’s decision to officially declare the shortages of Mounjaro and Zepbound, both forms of the GLP-1 drug tirzepatide, to be over in October. The suit was filed by the Outsourcing Facilities Association (OFA), a trade group that represents 503B compounding pharmacies, seeking to overturn the FDA’s decision.

After the suit was filed, the FDA temporarily paused to reconsider the declaration to end the shortage but ultimately reaffirmed its decision in December, finding once again that the supply of tirzepatide currently meets or exceeds demand.

Both Mounjaro and Zepbound are exclusive to Eli Lilly, but compounding pharmacies are permitted to make and sell copycat versions of such drugs when they’re in shortage. And in the nearly two years that tirzepatide was in shortage, telehealth companies, medical spas and other clients of compounding pharmacies were able to get in on the highly in-demand drug.

Following the FDA’s reaffirmation, 503B compounding pharmacies have until March 19 to stop selling compounded tirzepatide.

In its motion filed on New Year’s Day, Eli Lilly stated it seeks to “intervene as a defendant in this case to protect its interests and help bring this suit to a swift end.”

The pharmaceutical giant argued that the goal of OFA’s lawsuit, overturning the FDA’s determination that the tirzepatide shortage is over, would impair its ability to protect its interests. Eli Lilly cited the billions that it’s invested into this drug.

“Beyond the billions it spent developing, testing, and bringing to market its revolutionary medicines, Lilly has committed over $23 billion to increase its manufacturing capacity.”

The company also said it seeks to intervene because it does not believe the FDA adequately represents Eli Lilly’s interests. It argued that the FDA is not seeking to defend its declaration ending the shortage but is only seeking to defend its executive authority.

Additionally, it seeks to join the lawsuit as a defendant because the FDA may not file an appeal should a court rule in favor of the OFA.

“FDA’s decision resolving the tirzepatide shortage was correct, and the compounders’ lawsuit against FDA is without merit,” an Eli Lilly spokesperson said in a statement to The Hill. “Anyone marketing or selling unapproved tirzepatide knockoffs must stop.”

The OFA and FDA did not immediately respond when reached for comment.

Previous Post

Cruise ship stomach bug illnesses hit 12-year high: CDC

Next Post

More Popsicles, please: Your tonsils can grow back

Next Post
More Popsicles, please: Your tonsils can grow back

More Popsicles, please: Your tonsils can grow back

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025
    Bird flu can live in raw milk for more than a week, study finds

    Bird flu can live in raw milk for more than a week, study finds

    June 6, 2025

    Trending

    Minority in Florida snaps abortion rights winning streak

    Minority in Florida snaps abortion rights winning streak

    November 6, 2024
    Biden HHS secretary slams Trump NIH cuts: ‘It’s a demolition plan’

    Biden HHS secretary slams Trump NIH cuts: ‘It’s a demolition plan’

    May 2, 2025
    CDC denies Milwaukee’s request for help with unsafe lead levels in public schools

    CDC denies Milwaukee’s request for help with unsafe lead levels in public schools

    April 15, 2025
    Senate Democrats think risk of nixing filibuster for abortion is worth the reward

    Senate Democrats think risk of nixing filibuster for abortion is worth the reward

    September 29, 2024

    Recent News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025

    Popular News

    • A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges
    • Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.